A germ line mutation in cathepsin B points toward a role in asparaginase pharmacokinetics by Laurens T. van der Meer, Esmé Waanders, Marloes Levers, Hanka.

Slides:



Advertisements
Similar presentations
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Advertisements

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL by Arian.
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
Hypoxia increases IL-32 expression in an HIF1α-dependent manner.
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis by Samantha C. Gouw, H. Marijke.
Arg2074Cys missense mutation in the C2 domain of factor V causing moderately severe factor V deficiency: molecular characterization by expression of the.
Interleukin-5–producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy by Frédéric Van Gool, Ari B. Molofsky, Malika.
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels by Carina J. M. van Schooten,
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Functional study of the vitamin K cycle in mammalian cells
by Dörte Bechtel, Julia Kurth, Claus Unkel, and Ralf Küppers
The Role of Transcription Factor PU
Mutations of Chk2 in primary hematopoietic neoplasms
by Ji-Long Chen, Andre Limnander, and Paul B. Rothman
by Martha B. Johnson, and Caroline A. Enns
by Christina K. Ullrich, Jerome E. Groopman, and Ramesh K. Ganju
The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII by Kagehiro Amano,
High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations  Bjørnar Gilje, Reino Heikkilä, Satu.
Jacek Majewski  The American Journal of Human Genetics 
by Rong Chen, Michael J. Keating, Varsha Gandhi, and William Plunkett
by Sanjai Sharma, and Alan Lichtenstein
Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell.
Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation by Shiguo Zhu, Prasad V. Phatarpekar,
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11 by Michal.
by Thomas A. Paul, Juraj Bies, Donald Small, and Linda Wolff
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma by Thorsten Stühmer, Manik Chatterjee, Martin Hildebrandt, Pia.
by Beatriz Bellosillo, Mireia Dalmau, Dolors Colomer, and Joan Gil
Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential by Russell C. DeKelver, Ming Yan, Eun-Young Ahn, Wei-Jong.
Multiple myeloma–reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR)
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia by.
An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs and 1q21 amplification.
by Hiromi Gunshin, Carolyn N. Starr, Cristina DiRenzo, Mark D
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival by Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit.
by Eleanor J. Molloy, Amanda J. O'Neill, Julie J
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor by Anne F. Riddell,
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
by Sansana Sawasdikosol, Kristin M. Russo, and Steven J. Burakoff
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
High-Quality Genotyping Data from Formalin-Fixed, Paraffin-Embedded Tissue on the Drug Metabolizing Enzymes and Transporters Plus Array  Hanneke I. Vos,
CHK1 downregulation upon ERG overexpression.
by Kamira Maharaj, John J
Intestinal hephaestin potentiates iron absorption in weanling, adult, and pregnant mice under physiological conditions by Caglar Doguer, Jung-Heun Ha,
WNT ligands contribute to the immune response during septic shock and amplify endotoxemia-driven inflammation in mice by Marcela Gatica-Andrades, Dimitrios.
Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia by Jianting Long, Brian.
Gajja S. Salomons, Silvy J. M. van Dooren, Nanda M. Verhoeven, Kim M
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
by Megan S. Rost, Ilya Shestopalov, Yang Liu, Andy H. Vo, Catherine E
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes by Edward N. van den Brink, Ellen A. M. Turenhout,
Impact of RTEL1 variants on telomere maintenance.
Significant differences in translational efficiencies of DNA damage repair pathway genes between patient clusters. Significant differences in translational.
Premature Termination Codon Read-Through in the ABCC6 Gene: Potential Treatment for Pseudoxanthoma Elasticum  Yong Zhou, Qiujie Jiang, Shunsuke Takahagi,
Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans by Anne Jan van der Meer, Anna Kroeze,
Translational efficiency of ATM, MRN complex, and RIF1.
Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability by Georgette L. Suidan, Pradeep K. Singh,
Smith-Magenis Syndrome Results in Disruption of CLOCK Gene Transcription and Reveals an Integral Role for RAI1 in the Maintenance of Circadian Rhythmicity 
Marjolijn C. J. Jongmans, Eugene T. P
Identification and Characterization of a Mutation, in the Human UDP-Galactose-4- Epimerase Gene, Associated with Generalized Epimerase-Deficiency Galactosemia 
CD16 uses additional pathways for killing.
Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.
Volume 5, Issue 4, Pages (April 2007)
Volume 21, Issue 4, Pages (April 2013)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor.
by Xuefang Cao, Xingming Deng, and W. Stratford May
Ectopic expression of CA RSK1 mutant protects melanoma cells from PD98059-mediated apoptosis. Ectopic expression of CA RSK1 mutant protects melanoma cells.
HoxA9 is degraded by neutrophil granule proteases.
Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development by Jose A. Hernandez, Victoria L. Castro,
Patient Tregs express normal levels of suppression.
Presentation transcript:

A germ line mutation in cathepsin B points toward a role in asparaginase pharmacokinetics by Laurens T. van der Meer, Esmé Waanders, Marloes Levers, Hanka Venselaar, Debbie Roeleveld, Joachim Boos, Claudia Lanvers, Roger J. Brüggemann, Roland P. Kuiper, Peter M. Hoogerbrugge, Frank N. van Leeuwen, and D. Maroeska te Loo Blood Volume 124(19):3027-3029 November 6, 2014 ©2014 by American Society of Hematology

A mutation in the gene encoding cathepsin B in a patient with strongly reduced metabolism asparaginase. A mutation in the gene encoding cathepsin B in a patient with strongly reduced metabolism asparaginase. (A) Pharmacokinetics of Erwinase serum levels indicate a strongly delayed metabolism of ASNase in this patient. The half-life (ln2/Kel) of 28.5 hours (normal 7-15 hours5) was calculated using best-fit nonparametric modeling of the data points. (B) DNA sequencing of the cathepsin B gene reveals a heterozygous deletion of a single codon (c.709_711delAAG) in DNA isolated from PBMCs and buccal cells of the patient. (C) Cathepsin B activity in lysates of EBV-transformed B cells of the patient (carrying the mutation) and age-matched controls (N = 5) was determined by measuring cleavage of the fluorescent substrate Ac-RR-AFC. The plot shows an average of 2 experiments with standard deviation. One of the control samples was set to 1, and all samples were correlated to this sample. Unpaired 2-tailed t test was used to determine significance. (D) ASNase was incubated in lysate of HEK293 cells expressing wild-type or mutant cathepsin B. After incubation, residual ASNase activity was assayed as described in the supplemental Methods section. Cathepsin inhibitor CA-074 was included in selected samples to confirm the contribution of cathepsin B in this degradation. The plot shows an average of 3 independent experiments with standard error of the mean. Analysis of variance statistical analysis was applied to test for significance. Laurens T. van der Meer et al. Blood 2014;124:3027-3029 ©2014 by American Society of Hematology